Atlas Trials

A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma

Clinical trial NCT00872521 · COMPLETED

Trial details

NCT number
NCT00872521
Sponsor
Janssen-Cilag Pty Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2009-01-01
Primary completion
2011-03-01
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.